BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rochat MA, Schlaepfer E, Speck RF. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV. J Virol 2017;91:e02084-16. [PMID: 27928016 DOI: 10.1128/JVI.02084-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Inderbitzin A, Loosli T, Opitz L, Rusert P, Metzner KJ. Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4+ T cells: A pooled data-analysis. Front Immunol 2022;13:915805. [DOI: 10.3389/fimmu.2022.915805] [Reference Citation Analysis]
2 Chen J, Zhou T, Zhang Y, Luo S, Chen H, Chen D, Li C, Li W. The reservoir of latent HIV. Front Cell Infect Microbiol 2022;12:945956. [DOI: 10.3389/fcimb.2022.945956] [Reference Citation Analysis]
3 Abana CZ, Lamptey H, Bonney EY, Kyei GB. HIV cure strategies: which ones are appropriate for Africa? Cell Mol Life Sci 2022;79:400. [PMID: 35794316 DOI: 10.1007/s00018-022-04421-z] [Reference Citation Analysis]
4 Ahlenstiel CL, Symonds G, Kent SJ, Kelleher AD. Block and Lock HIV Cure Strategies to Control the Latent Reservoir. Front Cell Infect Microbiol 2020;10:424. [PMID: 32923412 DOI: 10.3389/fcimb.2020.00424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
5 Ait-Ammar A, Kula A, Darcis G, Verdikt R, De Wit S, Gautier V, Mallon PWG, Marcello A, Rohr O, Van Lint C. Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. Front Microbiol 2019;10:3060. [PMID: 32038533 DOI: 10.3389/fmicb.2019.03060] [Cited by in Crossref: 28] [Cited by in F6Publishing: 55] [Article Influence: 14.0] [Reference Citation Analysis]
6 Meås HZ, Haug M, Beckwith MS, Louet C, Ryan L, Hu Z, Landskron J, Nordbø SA, Taskén K, Yin H, Damås JK, Flo TH. Sensing of HIV-1 by TLR8 activates human T cells and reverses latency. Nat Commun 2020;11:147. [PMID: 31919342 DOI: 10.1038/s41467-019-13837-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
7 Ndung'u T, McCune JM, Deeks SG. Why and where an HIV cure is needed and how it might be achieved. Nature 2019;576:397-405. [PMID: 31853080 DOI: 10.1038/s41586-019-1841-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
8 Macedo AB, Novis CL, Bosque A. Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists. Front Immunol 2019;10:2450. [PMID: 31681325 DOI: 10.3389/fimmu.2019.02450] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
9 Sadowski I, Hashemi FB. Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs. Cell Mol Life Sci 2019;76:3583-600. [PMID: 31129856 DOI: 10.1007/s00018-019-03156-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
10 Yamamoto T, Kanuma T, Takahama S, Okamura T, Moriishi E, Ishii KJ, Terahara K, Yasutomi Y. STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques. Sci Rep. 2019;9:5917. [PMID: 30976083 DOI: 10.1038/s41598-019-42253-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
11 Castro-Gonzalez S, Colomer-Lluch M, Serra-Moreno R. Barriers for HIV Cure: The Latent Reservoir. AIDS Res Hum Retroviruses 2018;34:739-59. [PMID: 30056745 DOI: 10.1089/AID.2018.0118] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
12 Darcis G, Das AT, Berkhout B. Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies. Viruses 2018;10:E157. [PMID: 29596334 DOI: 10.3390/v10040157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
13 Spivak AM, Planelles V. Novel Latency Reversal Agents for HIV-1 Cure. Annu Rev Med 2018;69:421-36. [PMID: 29099677 DOI: 10.1146/annurev-med-052716-031710] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 17.2] [Reference Citation Analysis]